Carlos Vozzi

Is There Evidence of Benefit in Edetate Disodium for Patients with Diabetes and Chronic Limb-Threatening Ischemia?

Purpose: Patients with chronic limb-threatening ischemia (CLTI) remain at high risk for lower extremity amputations and death. Even with the advent of lower extremity endovascular revascu...

Francisco Ujueta , MD, MS;

Carlos Vozzi ;

Robert E. Beasley , MD, FSCAI, FSIR;

Gervasio A. Lamas , MD;

01/17/2022

Original Research

Edetate Disodium Infusions May Benefit Patients With Diabetes and Critical Limb-Threatening Ischemia

05/16/2022

Francisco Ujueta , MD, MS;

Carlos Vozzi ;

Ivan A. Arenas , MD, PhD;

Gervasio A. Lamas , MD;

Outcomes of CLTI patients with diabetes who underwent edetate disodium-based infusions.

Outcomes of CLTI patients with...

05/16/2022

Vascular Disease Management

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

March 27 ⁠–⁠ March 30

See Full Calendar

Carlos Vozzi

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products